ArticleOncology letters2012

Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.

Mine Erguven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.